name:-0.15581607818604
name:-0.12555503845215
name:-0.062350034713745
Intercept Pharmaceuticals, Inc. Patent Filings

Intercept Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Intercept Pharmaceuticals, Inc..The latest application filed is for "pharmaceutical compositions for combination therapy".

Company Profile
86.98.90
  • Intercept Pharmaceuticals, Inc. - Morristown NJ US
  • Intercept Pharmaceuticals, Inc. - New York NY US
  • INTERCEPT PHARMACEUTICALS, INC.; - US
  • Intercept Pharmaceuticals, Inc. - 421 Hudson Street, Suite 212 New York NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Pharmaceutical Compositions For Combination Therapy
App 20220280533 - PRUZANSKI; Mark ;   et al.
2022-09-08
Pharmaceutical Compositions For Combination Therapy
App 20220280534 - PRUZANSKI; Mark ;   et al.
2022-09-08
Medicine obtained by combining FXR agonist and ARB
Grant 11,419,878 - Namisaki , et al. August 23, 2
2022-08-23
Oral preparation of obeticholic acid
Grant 11,413,295 - Matono , et al. August 16, 2
2022-08-16
Pharmaceutical Compositions Comprising A Fxr Agonist And A Fibrate For Use In The Treatment Of Cholestatic Liver Disease
App 20220226350 - MACCONELL; Leigh A. ;   et al.
2022-07-21
Methods Of Using Obeticholic Acid
App 20220184099 - EDWARDS; Jeffrey ;   et al.
2022-06-16
TGR5 modulators and methods of use thereof
Grant 11,345,721 - Pellicciari , et al. May 31, 2
2022-05-31
Film-coated tablet having high chemical stability of active ingredient
Grant 11,331,273 - Matono , et al. May 17, 2
2022-05-17
Compositions Of Obeticholic Acid And Methods Of Use
App 20220133745 - LANCASTER; Richard Gail ;   et al.
2022-05-05
3-desoxy derivative and pharmaceutical compositions thereof
Grant 11,319,337 - Pellicciari , et al. May 3, 2
2022-05-03
Methods And Intermediates For The Preparation Of Bile Acid Derivatives
App 20220127302 - PELLICCIARI; Roberto ;   et al.
2022-04-28
Pharmaceutical compositions for combination therapy
Grant 11,311,557 - Pruzanski , et al. April 26, 2
2022-04-26
Treatment And Prevention Of Intestinal Inflammatory Diseases With A Bile Acid Derivative
App 20220096495 - CEULEMANS; Laurens ;   et al.
2022-03-31
Preparation And Uses Of Obeticholic Acid
App 20210395293 - STEINER; Andre ;   et al.
2021-12-23
Treatment Of Fibrosis Using Fxr Ligands
App 20210346400 - FIORUCCI; Stefano ;   et al.
2021-11-11
Tgr5 Modulators And Methods Of Use Thereof
App 20210269473 - PELLICCIARI; Roberto
2021-09-02
Farnesoid X Receptor Modulators
App 20210269475 - PELLICCIARI; Roberto ;   et al.
2021-09-02
Farnesoid X Receptor Modulators
App 20210228599 - PELLICCIARI; Roberto
2021-07-29
Methods and intermediates for the preparation bile acid derivatives
Grant 11,072,631 - Schaab , et al. July 27, 2
2021-07-27
Methods and intermediates for the preparation of bile acid derivatives
Grant 11,066,437 - Pellicciari , et al. July 20, 2
2021-07-20
Farnesoid X receptor modulators
Grant 11,034,717 - Pellicciari , et al. June 15, 2
2021-06-15
Crystalline Forms Of Obeticholic Acid
App 20210139528 - GALVIN; Gabriel M. ;   et al.
2021-05-13
Farnesoid x receptor modulators
Grant 11,000,532 - Pellicciari May 11, 2
2021-05-11
Tgr5 Modulators And Methods Of Use Thereof
App 20210122779 - PELLICCIARI; Roberto ;   et al.
2021-04-29
Treatment of fibrosis using FXR ligands
Grant 10,987,362 - Fiorucci , et al. April 27, 2
2021-04-27
3-desoxy Derivative And Pharmaceutical Compositions Thereof
App 20210101927 - Pellicciari; Roberto ;   et al.
2021-04-08
FXR agonist compositions for combination therapy
Grant 10,894,054 - Pruzanski , et al. January 19, 2
2021-01-19
Treatment Of Fibrosis Using Fxr Ligands
App 20200397803 - Fiorucci; Stefano ;   et al.
2020-12-24
3-desoxy derivative and pharmaceutical compositions thereof
Grant 10,815,267 - Pellicciari , et al. October 27, 2
2020-10-27
Steroids as agonists for FXR
Grant RE48,286 - Pellicciari October 27, 2
2020-10-27
TGR5 modulators and methods of use thereof
Grant 10,800,807 - Pellicciari , et al. October 13, 2
2020-10-13
Methods Of Diagnosis And Treatment Of Liver Diseases Using Obeticholic Acid
App 20200316092 - EDWARDS; Jeffrey ;   et al.
2020-10-08
Farnesoid X Receptor Modulators
App 20200297739 - Pellicciari; Roberto
2020-09-24
Compositions of obeticholic acid and methods of use
Grant 10,758,549 - Lancaster , et al. Sep
2020-09-01
Film-coated Tablet Having High Chemical Stability Of Active Ingredient
App 20200268671 - MATONO; Mitsuhiro ;   et al.
2020-08-27
Compositions of obeticholic acid and methods of use
Grant 10,751,349 - Lancaster , et al. A
2020-08-25
Methods And Intermediates For The Preparation Bile Acid Derivatives
App 20200239515 - Schaab; Kevin ;   et al.
2020-07-30
Compositions Of Obeticholic Acid And Methods Of Use
App 20200171053A1 -
2020-06-04
Pharmaceutical Compositions Of A Bile Acid Derivative And Microbiome And Uses Thereof
App 20200164005 - Wu; Gary D ;   et al.
2020-05-28
Isotopically Labeled Bile Acid Derivatives
App 20200165290 - GALVIN; Gabriel ;   et al.
2020-05-28
Methods Of Using Obeticholic Acid
App 20200147108 - Edwards; Jeffrey ;   et al.
2020-05-14
Compositions of obeticholic acid and methods of use
Grant 10,646,499 - Lancaster , et al.
2020-05-12
Methods for the preparation of obeticholic acid and derivatives thereof
Grant 10,604,545 - Galvin
2020-03-31
Methods for preparation of bile acids and derivatives thereof
Grant 10,604,544 - Galvin
2020-03-31
Compositions Of Obeticholic Acid And Methods Of Use
App 20200054650 - Lancaster; Richard Gail ;   et al.
2020-02-20
Compositions Of Obeticholic Acid And Methods Of Use
App 20200046735 - Lancaster; Richard Gail ;   et al.
2020-02-13
Compositions Of Obeticholic Acid And Methods Of Use
App 20200046736 - Lancaster; Richard Gail ;   et al.
2020-02-13
Methods of promoting hepatic regeneration
Grant 10,548,906 - Jansen , et al. Fe
2020-02-04
Methods for the preparation of obeticholic acid and derivatives thereof
Grant 10,550,146 - List , et al. Fe
2020-02-04
Crystalline Forms Of A Bile Acid Derivative
App 20200024299 - Strazik; Rachel Pineda ;   et al.
2020-01-23
Farnesoid X receptor modulators
Grant 10,532,061 - Pellicciari Ja
2020-01-14
Methods Of Treating Cancer
App 20190298742 - Moschetta; Antonio ;   et al.
2019-10-03
Steroids As Agonists For Fxr
App 20190300564 - Pellicciari; Roberto
2019-10-03
Steroids as agonists for FXR
Grant 10,421,772 - Pellicciari Sept
2019-09-24
Tgr5 Modulators And Methods Of Use Thereof
App 20190284225 - PELLICCIARI; Roberto ;   et al.
2019-09-19
Methods for preparation of bile acids and derivatives thereof
Grant 10,414,791 - Pellicciari , et al. Sept
2019-09-17
Compositions Of Obeticholic Acid And Methods Of Use
App 20190255071 - Lancaster; Richard Gail ;   et al.
2019-08-22
Methods of treating cancer
Grant 10,369,160 - Moschetta , et al.
2019-08-06
Methods For The Preparation Of Obeticholic Acid And Derivatives Thereof
App 20190211052 - List; Benjamin ;   et al.
2019-07-11
Farnesoid X Receptor Modulators
App 20190209586 - Pellicciari; Roberto
2019-07-11
Preparation and Uses of Obeticholic Acid
App 20190153020 - Steiner; Andre ;   et al.
2019-05-23
Treatment of fibrosis using FXR ligands
Grant 10,258,633 - Fiorucci , et al.
2019-04-16
Compositions Of Obeticholic Acid And Methods Of Use
App 20190076446 - Lancaster; Richard Gail ;   et al.
2019-03-14
Process for preparing bile acid derivatives
Grant 10,202,414 - Pellicciari , et al. Feb
2019-02-12
Methods For Preparation Of Bile Acids And Derivatives Thereof
App 20190010184 - Pellicciari; Roberto ;   et al.
2019-01-10
Preparation and uses of obeticholic acid
Grant 10,174,073 - Steiner , et al. J
2019-01-08
3-desoxy Derivative And Pharmaceutical Compositions Thereof
App 20190002493 - Pellicciari; Roberto ;   et al.
2019-01-03
Methods And Intermediates For The Preparation Of Bile Acid Derivatives
App 20180371009 - Pellicciari; Roberto ;   et al.
2018-12-27
Preparation and uses of obeticholic acid
Grant 10,155,787 - Steiner , et al. Dec
2018-12-18
Preparation and Uses of Obeticholic Acid
App 20180305397 - Steiner; Andre ;   et al.
2018-10-25
Methods Of Treating Cancer
App 20180256600 - Moschetta; Antonio ;   et al.
2018-09-13
Methods Of Promoting Hepatic Regeneration
App 20180256602 - Jansen; Peter Leonardus Maria ;   et al.
2018-09-13
Compositions of obeticholic acid and methods of use
Grant 10,052,337 - Lancaster , et al. August 21, 2
2018-08-21
Preparation and uses of obeticholic acid
Grant 10,047,117 - Steiner , et al. August 14, 2
2018-08-14
Methods For Preparation Of Bile Acids And Derivatives Thereof
App 20180222937 - Galvin; Gabriel M
2018-08-09
Preparation and uses of obeticholic acid
Grant 9,982,008 - Steiner , et al. May 29, 2
2018-05-29
Pharmaceutical Compositions For Combination Therapy
App 20180117065 - PRUZANSKI; Mark ;   et al.
2018-05-03
Treatment of Pulmonary Disease
App 20180064729 - Pruzanski; Mark ;   et al.
2018-03-08
Methods For Modulating Bone Density
App 20180042943 - Shapiro; David ;   et al.
2018-02-15
TGR5 Modulators and Methods of Use Thereof
App 20180016295 - Pellicciari; Roberto
2018-01-18
Pharmaceutical Compositions For Combination Therapy
App 20180008616 - Pruzanski; Mark ;   et al.
2018-01-11
Steroids as Agonists for FXR
App 20170305961 - Pellicciari; Roberto
2017-10-26
Methods Of Treating Cancer
App 20170296556 - Moschetta; Antonio ;   et al.
2017-10-19
Process for preparing bile acid derivatives
Grant 9,777,038 - Pellicciari , et al. October 3, 2
2017-10-03
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 9,763,964 - Pellicciari , et al. September 19, 2
2017-09-19
3-desoxy Derivative And Pharmaceutical Compositions Thereof
App 20170260225 - Pellicciari; Roberto ;   et al.
2017-09-14
Preparation and uses of obeticholic acid
Grant 9,732,116 - Steiner , et al. August 15, 2
2017-08-15
Steroids as agonists for FXR
Grant 9,732,117 - Pellicciari August 15, 2
2017-08-15
Preparation and Uses of Obeticholic Acid
App 20170226149 - Steiner; Andre ;   et al.
2017-08-10
Farnesoid X Receptor Modulators
App 20170216316 - Pellicciari; Roberto
2017-08-03
Treatment Of Fibrosis Using Fxr Ligands
App 20170165277 - Fiorucci; Stefano ;   et al.
2017-06-15
TGR5 modulators and methods of use thereof
Grant 9,650,409 - Pellicciari May 16, 2
2017-05-16
Farnesoid X Receptor Modulators
App 20170101434 - Pellicciari; Roberto ;   et al.
2017-04-13
Farnesoid X receptor modulators
Grant 9,611,289 - Pellicciari April 4, 2
2017-04-04
Compositions Of Obeticholic Acid And Methods Of Use
App 20170035784 - Lancaster; Richard Gail ;   et al.
2017-02-09
TGR5 modulators and methods of use thereof
Grant 9,540,414 - Pellicciari January 10, 2
2017-01-10
Treatment of fibrosis using FXR ligands
Grant 9,498,484 - Fiorucci , et al. November 22, 2
2016-11-22
Treatment of Pulmonary Disease
App 20160213689 - Pruzanski; Mark ;   et al.
2016-07-28
Preparation and Uses of Obeticholic Acid
App 20160215014 - Steiner; Andre ;   et al.
2016-07-28
Preparation and Uses of Obeticholic Acid
App 20160176913 - Steiner; Andre ;   et al.
2016-06-23
Steroids as Agonists for FXR
App 20160152657 - Pellicciari; Roberto
2016-06-02
Preparation and Uses of Obeticholic Acid
App 20160108082 - Steiner; Andre ;   et al.
2016-04-21
TGR5 Modulators and Methods of Use Thereof
App 20160096862 - Pellicciari; Roberto
2016-04-07
Preparation and Uses of Obeticholic Acid
App 20160074419 - Steiner; Andre ;   et al.
2016-03-17
Tgr5 Modulators And Methods Of Use Thereof
App 20160052956 - Pellicciari; Roberto
2016-02-25
TGR5 modulators and methods of use thereof
Grant 9,243,027 - Pellicciari January 26, 2
2016-01-26
Preparation and uses of obeticholic acid
Grant 9,238,673 - Steiner , et al. January 19, 2
2016-01-19
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions
App 20150359805 - Pellicciari; Roberto ;   et al.
2015-12-17
Process For Preparing Bile Acid Derivatives
App 20150291653 - Pellicciari; Roberto ;   et al.
2015-10-15
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 9,090,652 - Pellicciari , et al. July 28, 2
2015-07-28
Steroids as Agonists for FXR
App 20150166598 - Pellicciari; Roberto
2015-06-18
TGR5 modulators and methods of use thereof
Grant 8,999,964 - Pellicciari April 7, 2
2015-04-07
Steroids as agonists for FXR
Grant 8,969,330 - Pellicciari March 3, 2
2015-03-03
TGR5 modulators and methods of use thereof
Grant 8,796,249 - Pellicciari August 5, 2
2014-08-05
Treatment of Pulmonary Disease
App 20140148428 - Pruzanski; Mark ;   et al.
2014-05-29
TGR5 Modulators and Methods of Use Thereof
App 20140100209 - Pellicciari; Roberto
2014-04-10
TGR5 Modulators and Methods of Use Thereof
App 20140094443 - Pellicciari; Roberto
2014-04-03
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions
App 20140057886 - Pellicciari; Roberto ;   et al.
2014-02-27
Steroids as Agonists for FXR
App 20140024631 - Pellicciari; Roberto
2014-01-23
Preparation and Uses of Obeticholic Acid
App 20130345188 - Steiner; Andre ;   et al.
2013-12-26
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 8,546,365 - Pellicciari , et al. October 1, 2
2013-10-01
TGR5 modulators and methods of use thereof
Grant 8,445,472 - Pellicciari May 21, 2
2013-05-21
23-substituted bile acids as TGR5 modulators and methods of use thereof
Grant 8,410,083 - Pellicciari April 2, 2
2013-04-02
Steroids as agonists for FXR
Grant 8,377,916 - Pellicciari February 19, 2
2013-02-19
Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions
App 20120283234 - Pellicciari; Roberto ;   et al.
2012-11-08
TGR5 Modulators and Methods of Use Thereof
App 20120115832 - Pellicciari; Roberto
2012-05-10
Steroids as Agonists for FXR
App 20120053163 - Pellicciari; Roberto
2012-03-01
TGR5 modulators and methods of use thereof
Grant 8,114,862 - Pellicciari February 14, 2
2012-02-14
Steroids as agonists for FXR
Grant 8,058,267 - Pellicciari November 15, 2
2011-11-15
Process for preparing 3a(.beta.)-7a(.beta.)-dihydroxy-6a(.beta.)-alkyl-5.beta.-cholanic acid
Grant 7,994,352 - Ferrari , et al. August 9, 2
2011-08-09
TGR5 Modulators And Methods Of Use Thereof
App 20110172198 - Pellicciari; Roberto
2011-07-14
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 7,932,244 - Pellicciari , et al. April 26, 2
2011-04-26
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 7,858,608 - Pellicciari , et al. December 28, 2
2010-12-28
Steroid agonist for FXR
Grant 7,812,011 - Pellicciari October 12, 2
2010-10-12
Steroids as agonists for FXR
Grant 7,786,102 - Pellicciari August 31, 2
2010-08-31
Tgr5 Modulators And Methods Of Use Therof
App 20100152151 - Pellicciari; Roberto
2010-06-17
Bile Acid Derivatives As Fxr Ligands For The Prevention Or Treatment Of Fxr-mediated Diseases Or Conditions
App 20100063018 - Pellicciari; Roberto ;   et al.
2010-03-11
Steroids As Agonists For Fxr
App 20100022498 - Pellicciari; Roberto
2010-01-28
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
App 20080182832 - Pellicciari; Roberto ;   et al.
2008-07-31
Novel Steroid Agonist For Fxr
App 20080039435 - Pellicciari; Roberto
2008-02-14
Steroids as agonists for FXR
App 20070142340 - Pellicciari; Roberto
2007-06-21
Method of reducing drug-induced adverse side effects in a patient
App 20060252670 - Fiorucci; Stefano ;   et al.
2006-11-09
Treatment of fibrosis using FXR ligands
App 20060069070 - Fiorucci; Stefano ;   et al.
2006-03-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed